05:19 PM EDT, 07/11/2024 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) filed a registration statement Thursday covering the potential sale of up to $300 million of its securities from time to time.

The filing covers common stock, preferred stock, debt securities, warrants, subscription rights and units.

The company plans to use the net proceeds for general corporate purposes.

Price: 12.42, Change: -0.08, Percent Change: -0.64